Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder
NCT ID: NCT01260311
Last Updated: 2014-09-11
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
508 participants
OBSERVATIONAL
2011-02-28
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous Therapy
NCT00691093
An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia
NCT00605319
Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder.
NCT00611026
Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.
NCT00561951
Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children.
NCT02614482
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients prescribed with Fesoterodine
Patients diagnosed with Over-active bladder and prescribed with fesoterodine.
Fesoterodine
Any dose of Fesoterodine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fesoterodine
Any dose of Fesoterodine
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Prescribed with Fesoterodine
Exclusion Criteria
* Urinary retention
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mary Johnston Hospital, Inc.
Tondo, Manila, Philippines
East Avenue Medical Center
Diliman, Quezon City, National Capital Region, Philippines
The Medical City
Pasig, National Capital Region, Philippines
St. Luke's Medical Center
Quezon City, National Capital Region, Philippines
Private Clinic
Baguio City, , Philippines
Private Clinic
Batangas, , Philippines
Cebu Doctors Hospital, Osmena Blvd.,
Cebu, , Philippines
Private Clinic
City of Muntinlupa, , Philippines
Davao Doctors Hospital
Davao City, , Philippines
Davao Doctors Tower
Davao City, , Philippines
Davao Medical School Foundation Hospital
Davao City, , Philippines
Private Clinic
Davao City, , Philippines
Room 120, Davao Medical School Foundation Hospital
Davao City, , Philippines
Private Clinic
Ilocos Norte, , Philippines
Private Clinic
La Union, , Philippines
Private Clinic
Laguna, , Philippines
Lucena United Doctors Hospital
Lucena City, , Philippines
Makati Medical Center
Makati City, , Philippines
Private Clinic
Makati City, , Philippines
Room 314 Main Building
Makati City, , Philippines
VRPMC
Mandaluyong, , Philippines
Medical Center Manila
Manila, , Philippines
University of Sto. Tomas Hospital
Manila, , Philippines
Ospital ng Maynila Medical Center
Manila, , Philippines
Private Clinic
Manila, , Philippines
Santo Tomas University Hospital
Manila, , Philippines
Private Clinic
Nueva Ecija, , Philippines
Healthway Medical, The Block
Philippines, , Philippines
East Avenue Medical Center
Quezon, , Philippines
Private Clinic
Quezon, , Philippines
St. Luke's Medical Center, North Tower, CHBC
Quezon City, , Philippines
Private Clinic
Quezon City, , Philippines
Private Clinic
South Luzon, , Philippines
Central Luzon Doctor's Hospital
Tarlac City, , Philippines
Fatima Medical Center, Inc.
Valenzuela, , Philippines
F.E.U. - Nicanor Reyes Medical Foundation Medical Center
West Fairview, Quezon City, , Philippines
Urology Clinic
Zamboanga City, , Philippines
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A0221085
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.